T1	Condition 0 14	Morbidly obese
T2	Measurement 25 28	BMI
T3	Value 29 38	>47 kg/m2
R1	Has_value Arg1:T2 Arg2:T3	
T4	Condition 44 54	overweight
T5	Condition 55 59	lean
T6	Measurement 70 73	BMI
T7	Value 74 83	<27 kg/m2
R2	Has_value Arg1:T6 Arg2:T7	
T8	Scope 25 38	BMI >47 kg/m2
R3	Subsumes Arg1:T1 Arg2:T8	
T9	Scope 70 83	BMI <27 kg/m2
*	OR T4 T5
T10	Scope 44 59	overweight/lean
R4	Subsumes Arg1:T10 Arg2:T9	
T11	Scope 44 84	overweight/lean patients (BMI <27 kg/m2)
*	OR T1 T10
T12	Condition 98 113	type 1 diabetes
T13	Condition 118 127	diabetics
T14	Qualifier 128 153	requiring insulin therapy
T15	Procedure 138 153	insulin therapy
T16	Drug 138 145	insulin
R5	multi Arg1:T15 Arg2:T16	
R6	multi Arg1:T14 Arg2:T15	
R7	Has_qualifier Arg1:T13 Arg2:T14	
*	OR T12 T13
T17	Negation 174 177	not
T18	Observation 183 196	weight stable
T19	Value 198 203	>2 kg
T20	Measurement 204 217	weight change
R9	Has_value Arg1:T20 Arg2:T19	
T21	Temporal 218 234	in past 3 months
R10	Has_temporal Arg1:T20 Arg2:T21	
T22	Scope 198 234	>2 kg weight change in past 3 months
R8	Has_negation Arg1:T18 Arg2:T17	
T23	Scope 174 196	not been weight stable
R11	Subsumes Arg1:T23 Arg2:T22	
T24	Temporal 260 268	recently
T25	Condition 269 275	active
T26	Value 277 284	>30 min
T27	Measurement 288 320	moderate/high intensity exercise
R12	Has_value Arg1:T27 Arg2:T26	
T28	Multiplier 322 334	2 times/week
R13	Has_multiplier Arg1:T27 Arg2:T28	
T29	Scope 277 334	>30 min of moderate/high intensity exercise, 2 times/week
R14	Subsumes Arg1:T25 Arg2:T29	
T30	Scope 269 335	active (>30 min of moderate/high intensity exercise, 2 times/week)
R15	Has_temporal Arg1:T30 Arg2:T24	
T31	Observation 355 362	smokers
T32	Observation 375 387	quit smoking
T33	Temporal 388 400	<5 years ago
R16	Has_temporal Arg1:T32 Arg2:T33	
*	OR T31 T32
T34	Drug 422 431	metformin
T35	Drug 446 455	metformin
T36	Temporal 456 469	within 1 year
R17	Has_temporal Arg1:T35 Arg2:T36	
*	OR T34 T35
T37	Value 486 494	abnormal
T38	Measurement 495 538	estimated glomerular filtration rate (eGFR)
R18	Has_value Arg1:T38 Arg2:T37	
T39	Condition 541 561	Hypertriglyceridemic
T40	Value 563 573	>400 mg/dl
T41	Measurement 541 561	Hypertriglyceridemic
R19	Has_value Arg1:T41 Arg2:T40	
R20	multi Arg1:T39 Arg2:T41	
T42	Condition 579 599	hypercholesterolemic
T43	Measurement 584 595	cholesterol
T44	Value 601 611	>260 mg/dl
R21	Has_value Arg1:T43 Arg2:T44	
R22	multi Arg1:T42 Arg2:T43	
*	OR T39 T42
T45	Condition 623 635	Hypertensive
T46	Value 637 650	>160/100 mmHg
T47	Measurement 623 635	Hypertensive
R23	Has_value Arg1:T47 Arg2:T46	
R24	multi Arg1:T45 Arg2:T47	
T48	Drug 679 690	medications
T49	Qualifier 691 713	that affect heart rate
T50	Qualifier 691 708;718 724	that affect heart rhythm
R25	Has_qualifier Arg1:T48 Arg2:T50	
R26	Has_qualifier Arg1:T48 Arg2:T49	
T51	Drug 731 752	Ca++ channel blockers
T52	Drug 754 762	nitrates
T53	Drug 764 770;779 787	alpha- blockers
T54	Drug 774 787	beta-blockers
*	OR T53 T54 T52 T51
T55	Scope 731 787	Ca++ channel blockers, nitrates, alpha- or beta-blockers
T56	Scope 679 724	medications that affect heart rate and rhythm
R27	Subsumes Arg1:T56 Arg2:T55	
T57	Observation 807 814	history
T58	Qualifier 818 829	significant
T59	Qualifier 830 839	metabolic
T60	Qualifier 841 848	cardiac
T61	Condition 850 874	congestive heart failure
T62	Qualifier 876 891	cerebrovascular
T63	Qualifier 893 906	hematological
T64	Qualifier 908 917	pulmonary
T65	Qualifier 919 935	gastrointestinal
T66	Qualifier 937 942	liver
T67	Qualifier 944 949	renal
T68	Qualifier 954 963	endocrine
T69	Condition 964 971	disease
*	OR T59 T60 T62 T63 T64 T65 T66 T67 T68
T70	Scope 830 963	metabolic, cardiac, congestive heart failure, cerebrovascular, hematological, pulmonary, gastrointestinal, liver, renal, or endocrine
T71	Condition 975 981	cancer
*	OR T69 T71 T73
T72	Non-query-able 982 1094	that in the investigator's opinion would interfere with or alter the outcome measures, or impact subject safety.
T73	Scope 850 874;964 981	congestive heart failure disease or cancer
R28	Has_scope Arg1:T73 Arg2:T70	
R29	Has_qualifier Arg1:T73 Arg2:T58	
R30	Has_temporal Arg1:T73 Arg2:T57	
T74	Condition 1096 1104	Pregnant
T75	Measurement 1131 1145	pregnancy test
T76	Value 1122 1130	positive
T77	Observation 1150 1157	nursing
R31	Has_value Arg1:T75 Arg2:T76	
*	OR T74 T77
T78	Person 1158 1163	women
R32	Subsumes Arg1:T74 Arg2:T75	
T79	Condition 1179 1196	contraindications
T80	Observation 1200 1245	participation in an exercise training program
R33	Has_context Arg1:T79 Arg2:T80	
T81	Drug 1264 1300	active weight suppression medication
T82	Drug 1307 1318	phentermine
T83	Drug 1319 1327	orlistat
T84	Drug 1329 1339	lorcaserin
T85	Drug 1341 1376	naltrexone-bupropion in combination
T86	Drug 1378 1389	liraglutide
T87	Drug 1391 1405	benzephetamine
T88	Drug 1407 1421	diethylpropion
T89	Drug 1423 1438	phendimetrazine
*	OR T83 T82 T84 T85 T86 T87 T88 T89
T90	Scope 1307 1438	phentermine,orlistat, lorcaserin, naltrexone-bupropion in combination, liraglutide, benzephetamine, diethylpropion, phendimetrazine
R34	Subsumes Arg1:T81 Arg2:T90	
T91	Condition 1447 1463	hypersensitivity
T92	Drug 1467 1477	perflutren
T93	Drug 1492 1500	Definity
R35	Subsumes Arg1:T92 Arg2:T93	
R36	AND Arg1:T91 Arg2:T92	
